Skip to content

AI Models for Predicting Occult Pleural Dissemination in NSCLC

Comparing Radiomics, Deep Learning, and Fusion Models for Predicting Occult Pleural Dissemination in Patients With Non-small Cell Lung Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07065422
Enrollment
326
Registered
2025-07-15
Start date
2023-12-13
Completion date
2025-01-01
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

Brief summary

Occult pleural dissemination (PD) in non-small cell lung cancer (NSCLC) patients is likely to be missed on computed tomography (CT) scans, associated with poor survival, and generally contraindicated for radical surgery. This study aimed to develop and compare the performance of radiomics-based machine learning (ML), deep learning (DL), and fusion models to preoperatively identify occult PDs in NSCLC patients. Patients from three Chinese high-volume medical centers (2016-2023) were retrospectively collected and divided into training, internal test, and external test cohorts. Ten radiomics-based ML models and eight DL models were trained using CT plain scan images at the maximum cross-sectional areas of the primary tumor. Moreover, another two fusion models (prefusion and postfusion) were developed using feature-based and decision-based methods. The receiver operating characteristic curve (ROC) and area under the curve (AUC) were mainly used to compare the predictive performance of the models.

Interventions

None listed

Sponsors

First Affiliated Hospital of Chongqing Medical University
CollaboratorOTHER
Xinqiao hospital of the third military medical university
CollaboratorUNKNOWN
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* pathologically confirmed primary NSCLC with malignant pleural dissemination; * no preoperative treatment; * clinicopathological data were complete.

Exclusion criteria

* pleural effusion detected preoperatively; * preoperatively diagnosed with PD; * poor CT quality or no CT scans within 1 month before surgery.

Design outcomes

Primary

MeasureTime frame
The area under the receiver operating characteristic curve (AUC)through study completion, an average of 6 months.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026